Key Takeaways
- Hexagon Nutrition IPO opens on 5–9 June 2026 with a price band of ₹42 to ₹45 and a lot size of 333 shares.
- Retail investors should note GMP data is not available yet for the Hexagon Nutrition IPO, creating listing uncertainty.
- Hexagon Nutrition IPO sits in the nutrition and consumer health space, a segment with steady demand but listing risk for new issues.
- If you have risk tolerance, apply in small allocations and monitor GMP signals and subscription data before committing more.
Hexagon Nutrition IPO - Key Details and Dates
Why Hexagon Nutrition IPO At ₹42–₹45 Band Sparks Retail Interest?
Hexagon Nutrition IPO is a main-board offer with a price band of ₹42 to ₹45 and an OFS structure, which makes listing dynamics crucial for first-day investors. The data points indicate a sizable issue size of ₹139 crore and a 333-share lot, attracting retail attention given the brand's focus on nutrition and health supplements.
Hexagon Nutrition IPO - Market Backdrop And OFS Details
The book-building IPO is open from 5 June to 9 June 2026, with the shares proposed to list on BSE and NSE on 12 June 2026. The OFS offer comprises 3,08,59,704 shares of ₹1 each, aggregating up to ₹139 crore, while GMP data is currently not available, creating uncertainty around listing gains. Kfin Technologies is the registrar (To be announced in final terms) and the process is led by a yet-to-be-announced lead manager.
HOW this affects specific holdings
The Hexagon Nutrition IPO introduces a fresh exposure to the nutrition and consumer health space, which could affect investors with large existing positions in health and FMCG names. If you already own related stocks, watch for a listing day price swing and consider hedges if risk appetite is low.
WHICH sectors/stocks by name
- 1st Priority: Consumer staples and healthcare-related stocks – typically bid up on positive demand for nutrition products
- 2nd Priority: Mid-cap FMCG/nutrition players with proven distribution – potential for follow-on earnings if listing gains materialize
- Avoid Now: IT and tech-heavy names – current market risk appetite may not be aligned with IPOs in non-core sectors
What SIP, Lumpsum and Traders Should Do Now
- SIP investors: Maintain existing allocations in quality funds and avoid large fresh allocations to this IPO until GMP data and subscription trends are clear.
- Lumpsum investors: If you choose to apply, do so in a small quantity and monitor GMP signals and listing demand before increasing exposure.
- Traders: Expect listing day volatility; use defined risk controls and set stop-loss if you participate in the listing trade rather than long-term holding.
Swastika Investmart notes that Hexagon Nutrition IPO's pricing sits at ₹42–₹45 with OFS and no GMP data yet, which can lead to listing volatility. Investors may consider applying in small allocations and monitor GMP data as listing approaches. Our IPO desk will track subscription trends and post-listing performance to guide further action.
Key Risks to Watch After Hexagon Nutrition IPO
- Valuation risk if demand fades post-listing and price stabilizes below issue price
- GMP data not available at subscription time may lead to mispricing and misinterpretation
- Listing-day volatility due to OFS structure and retail demand swings
FAQ
When does the Hexagon Nutrition IPO open?
It opens on 5 June 2026 and closes on 9 June 2026.
What is the IPO size and price band?
The issue consists of 3,08,59,704 shares aggregating up to ₹139 crore with a price band of ₹42 to ₹45 per share.
When will the shares be listed?
The listing date is Friday, 12 June 2026, on BSE and NSE.
Should retail investors apply for this IPO?
It depends on your risk tolerance; if you apply, keep allocations small, monitor GMP data and subscription trends, and consider waiting for listing clarity before committing large capital.
Conclusion
Hexagon Nutrition IPO presents a defined exposure to the nutrition space with a price band of ₹42–₹45. Given GMP data is not yet available, retail investors should proceed with caution, use small allocations if applying, and monitor subscription trends and GMP updates before increasing exposure.



.webp)

.avif)
.avif)

.avif)






